DNM1L identified as pancreatic cancer target

DISEASE CATEGORY: Cancer

INDICATION: Pancreatic cancer

Inhibiting DNM1L, a GTPase involved

Read the full 90 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE